Trans Health Guidelines - How important are these domains to stakeholders?
I am Catherine Meads, a Professor of Health at Anglia Ruskin University. My team are looking at how to best appraise trans health guidelines using a recognized tool called AGREE II  in order to make sure they are helping the trans community as well they should be and our protocol is here.
It is important when judging guidelines to know what the stakeholders for the intended audience think, so I would be very grateful to you for spending 1-2 minutes considering and prioritizing what matters most to you in guidelines to do with the health of trans people (including all gender diverse identities such as transgender, non-binary, gender queer, gender-fluid, gender nonconforming, agender, or any non-cis folk). These domains are set by the AGREE II developers .
Answers can be anonymous or just from an organisation without an individual’s name.
Please pass onto any other relevant organizations and reply by X date.
With many thanks in advance.
Prof Catherine Meads
 Brouwers M, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna S, Littlejohns P, Makarski J, Zitzelsberger L for the AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J. 2010. Available online July 5, 2010. doi:10.1503/cmaj.090449